Accessibility
Executive Committee
-
Lício Tavares Ângelo Cintra
Chief Executive Officer
(until June 30, 2025) -
Rafael Lucchesi
Chief Executive Officer
(from July 1, 2025) - André Covre Corporate Strategy Officer
- Rafael Bossolani Chief Financial and IR Officer
- Fábio Sampaio de Lacerda People, Management and Culture Executive Officer
- Helisson Brígido Andrade Lemos Product, Marketing, Analytics and Customer Experience Officer (PMAX)
- Leonardo Modesti Vedolin Medical and Production Officer
- Roberto Caldeira Cury Service Units and Customer Service Center Officer
- Anaterra Barros de Oliveira Technology Officer
- Linaldo Vilar Junior Production Director
(until June 30, 2025)
On June 27, 2023, Lício Tavares Ângelo Cintra was elected by the Board of Directors to hold the position of Chief Operations Officer until January 31, 2024, as part of the succession plan of the current CEO of the Company.
Before joining DASA, he was a member of the Board of Directors and Vice President – M&A and Commercial at Hapvida, besides working for 14 years at Grupo São Franciso, 10 years as head of the Group.
Lício holds a degree in Electrical Engineering from Universidade Presbiteriana Mackenzie, has completed a specialization program in Business Administration from FGV and holds an MBA in Controllership and Finance from USP (FUNDACE) and an International Executive MBA from FIA.
(from July 1, 2025)
Rafael Lucchesi was elected by the Board of Directors on May 2, 2017, to serve as the Company’s Director of Management and People.
He served as Director of the São Paulo Regional Office between 2015 and 2016, and as Director of New Business between 2013 and 2014. Before joining the Company, Rafael worked at Amil and Medial Saúde.
Rafael holds an MBA from FIA/USP and an MBA in Medical Management from Insper/Einstein.
Mr. Andre Covre was elected on August 24, 2023, by the Board of Directors to the position of Chief Financial Officer.
Before joining DASA, he worked for 15 years at the Ultra Group, as Chief Financial and Investor Relations Officer and CEO of Extrafarma. He has also worked for multinational companies such as Unisys Corporation in the United States and ABN AMRO Capital in Europe.
Andre has a degree in Public Administration from Fundação Getúlio Vargas and an MBA from INSEAD.
Mr. Rafael Bossolani is Dasa’s Chief Financial and IR Officer. With over 20 years of experience in the financial sector, his professional career includes companies such as International Meal Company, Hering, Chiesi, Walmart and Natura, with emphasis on his work in the areas of planning, controlling and investments. An economist, he has an MBA in Finance from Insper, in addition to additional training at Fundação Getúlio Vargas and Fox School of Business.
Mr. Fábio Lacerda was elected by the Board of Directors on March 6, 2025 to occupy the position of People, Management and Culture Executive Officer of the Diagnostics Unit.
The executive developed his career at companies like Cogna Educação and DHL, where he led cultural transformations, mergers and strategic initiatives.
In addition, he completed the Program for the Development of Board Members, Administration and Business (PDC) at Fundação Dom Cabral in 2024 and the Executive Program in Management and Innovation at StartSe University. In addition, he studied Organizational Psychology, Business Administration and Management at the Faculdade Brasileira de Recursos Humanos and completed a continuing education course in Finance at Fundação Getúlio Vargas (FGV).
Helisson Brígido Andrade Lemos was elected on May 15, 2023 to serve as Products, Marketing, Analytics and Customer Experience (PMAX) Officer.
Worked for more than 17 years in Mercado Livre (NASDAQ: MELI), a leading retailer and provider of digital financial services in Latin America, reaching the position of Country General Manager, responsible for the group’s operational and financial results in Brazil.
As COO of Movile, was coresponsible for creating governance and acceleration of the group’s technology investees.
More recently, he was VP of Digital Innovation at VIA (B3: VIIA3), responsible for kicking off the Company’s digital transformation and contributing to one of the greatest turnarounds in Brazilian retail. He is also an investor and serves on the boards of human resources, technology and educational companies.
Mr. Lemos holds a degree in business administration from the Fundação Getúlio Vargas, an MBA from Escola Superior de Propaganda e Marketing and an Executive MBA from the Stanford Graduate School of Business.
Leonardo was elected for the position of Dasa’s medical officer in 2017. Previously, Leonardo served as a neuro-radiology medical officer and coordinator at the Company.
Before joining Dasa, Leonardo served as a founding partner at Medvia Diagnóstico, and chief of radiology services at Clinics Hospital in Porto Alegre.
Leonardo holds a Ph.D. in medical sciences from the Federal University of Rio Grande do Sul (UFRGS). He holds a degree in medicine from PUCRS, with graduate studies in neuro-radiology from Mount Sinai School of Medicine and graduate studies in vascular neurology from Massachusetts General Hospital.
Mr. Roberto Caldeira Cury is Dasa’s Service Units and Customer Service Center Officer. He has been with the company since 2013, and has led areas such as Cardiology and Radiology, was executive director of Diagnostic Imaging LATAM and medical director of Diagnostic Medicine. He graduated in medicine from the Faculty of Medical Sciences of Santa Casa de São Paulo, completed his residency in Internal Medicine at the same institution and in Cardiology at Hospital do Coração. He has specializations in Tomography and Cardiac Resonance Imaging from the Heart Institute (InCor/FMUSP).
Mrs. Anaterra Oliveira is Dasa’s Technology Officer. She has over 20 years of experience in the segment, in addition to a decade in leadership and team management, having worked at companies such as Vtex, Nubank, Banco BV and Rede. She holds a bachelor’s degree in Information Technology Administration and Management from FASP and has specializations granted by renowned institutions such as Harvard Business School, Insead and Fundação Getúlio Vargas.
Linaldo was elected on July 25, 2016 by the Board of Directors to serve as Production Officer.
He has 25 years of experience in the Supply Chain area at companies such as Kenner, Giroflex-forma, Coca-Cola, Reckitt Benckiser, ABlnBev.
Linaldo holds a B.Sc. in Chemical Engineering from Catholic University of Pernambuco, an Executive MBA from Business School São Paulo and a Green Belt from Fundação Christiano Otonni. He also completed the Supply Chain Leadership Program from Georgia Tech, University of Georgia, USA.
Board of Directors
Dr. Dulce is co-chairwoman of Dasa’s board of directors. She dedicated her professional career to healthcare and hospital operations-related activities.
In 1971, Dr. Dulce co-founded Casa de Saúde São José, the inception of Grupo Amil. Dr. Dulce was controlling shareholder of Amil Assistência Médica Internacional, Ltda. founded in 1972, which became the largest health insurance provider and operator of various hospitals and clinics in Brazil. In 2012, this company was sold to UnitedHealth Group Inc., one of the USA’s leading healthcare companies.
Dr. Dulce also held the following positions: (i) co-founder and officer at Hospital SOMICOL, currently known as Hospital Mario Lioni, and the first pediatric intensive care unit in Latin America, from 1972 to 1984; (ii) superintendent at Amil Previdência Privada, insurance company, an arm of Grupo Amil, from 1984 to 1986; (iii) customer service officer at Amil, from 1986 to 1988; (iv) superintendent at ESHO – Empresa de Serviços Hospitalares S.A., a holding of 17 hospitals, from 1988 to 1990; (v) chairwoman of the boards of directors of Amil International Insurance Company, Inc. and Amil International (Texas), Inc., insurance companies, from 1996 to 2005; (vi) vice chairwoman of Amil Participações S.A.’s board of directors, from 2007 to 2012; (vii) chairwoman of the sustainability committee, from 2012 to 2013; and (viii) chairwoman of the boards of directors of Amil LifeSciences, from 2010 to 2014, and Excellion, from 2012 to 2014, both in the management of medical training companies and research.
Dr. Dulce holds a degree in medicine from the Federal University of Rio de Janeiro (UFRJ) in 1971. She holds the following titles at UFRJ: pediatric specialist in 1972, post-PhD in medicine (master’s degree) with specialization in pediatrics in 1976, and an MBA from COPPEAD in 1984. In 2000, she obtained a Ph.D. in business administration, with a specialization in health from the University of Texas, Austin. From 1973 to 1978, Dr. Dulce was an Assistant Professor in the Pediatrics Department of the Faculty of Medicine of the Catholic University of Petrópolis.
Pedro is a member of Dasa’s board of directors and served previously as the Company’s Chief Executive Officer from December 2014 to December 2023.
Mr. Bueno holds a degree in economics from the Pontifical Catholic University of Rio de Janeiro (PUC-RJ).
Currently, he is a partner of DNA Capital, a healthcare private equity firm.
Dr. Henrique is a member of Dasa’s board of directors.
Dr. Henrique held the following positions: (i) orthopedic surgeon at Hospital Rede Esho 2002 – 2005-Amil Resgate Saúde’s CEO, from 2005 to 2015; (ii) medical supplies officer at Amil International Insurance/United Healthcare and 32 hospitals, from 2005 to 2013; (iii) he participated in IPO and Road Show of Amil International Insurance, in October 2007; and, (iv) Hospital das Américas’ CEO, Brazil’s largest private hospital at that time, from 2009 to 2014.
Dr. Henrique has been a member of Rede Ímpar’s board of directors, since 2013 and Grupo Dasa, since 2016; also Patrys Investimentos Imobiliários LTDA’s CEO.
Dr. Henrique holds a degree in medicine from UNIG, Rio de Janeiro, in 2002. He holds the following titles: (i) orthopedic surgery – Federal University of Rio de Janeiro (UNI-RIO) 2003 – 2005; (ii) Executive MBA in health – UFRJ – COPPEAD – 2006 – 2007; (iii) corporate governance in family companies – IBGC (Brazilian Institute of Corporate Governance) – 2007; (iv) corporate governance in health – IBGC (Brazilian Institute of Corporate Governance) – 2009; (v) Harvard Business School – OPM IV (Owner/President Management) – 2011.
Mr. Stelleo is an independent board member of Dasa.
Mr. Stelleo holds a bachelor’s degree and a Master’s degree in Mechanical Engineering from Stanford University with an MBA from Stanford Graduate School of Business. Mr. Stelleo is advisor and co-founder of Mercado Libre (NASDAQ: MELI), Latin America’s leading retail and online financial services company, over the past 23 years, he led the Brazilian operation, as regional COO and e-commerce officer. Mr. Stelleo also acts as investor, board member, and mentor for IT, consumer, education and fintech segments.
Maria Letícia de Freitas Costa is a member of the Board of Directors of Dasa. She is currently a partner at SLP Consultoria e Treinamento and serves on the Boards of Localiza S.A., Mapfre S.A., Auren Energia S.A. and Totvs S.A. Earlier, she served on the Boards of Technip S.A., Sadia S.A., Martins, Gafisa, Embraer and Marcopolo, and on the advisory committees to the Board of Directors of Votorantim Industrial, Votorantim Metais, CBA and Bematech. Maria Letícia holds a degree in Production Engineering from the Polytechnic
School of the University of São Paulo and an MBA from the Cornell University SC Johnson College of Business.
Audit Committee
Mrs. Viviane Pinto Mendes holds the position of a member of the audit committee of Dasa and controllership manager at Signo Investimentos.
Her professional experience over the past five years includes Rede Impar and Signo Investimentos, companies in the health and investments sectors, respectively. Previously, she held the positions of internal controls manager, controller, member of the audit committee, and executive.
Currently, Romeu holds the positions of co-chairman of the board of directors and member of the Company’s audit committee.
Mr. Domingues served as scientific director at Colégio Brasileiro de Radiologia e Diagnóstico por Imagem; in 2011 he held the position of chief imaging officer at Dasa. In 2012, he held the position of Dasa’s chief executive officer.
Romeu holds a degree in medicine from the Federal University of Rio de Janeiro in 1986, with a medical residency in radiology and diagnostic imaging. He completed graduate studies from Harvard University, with a qualification in magnetic resonance imaging.
Denis Cuenca was elected Coordinator of the Audit Committee by the Board of Directors on April 16, 2024.
Denis holds a bachelor’s degree in Business Administration and an MBA in Business Management. He has 35 years of executive experience in External and Internal Audit, Risk and Crisis Management, Compliance, Integrity Management and Whistleblowing Channel at KPMG, Itaú and Ultrapar.
Currently, he is Chief Global Audit and Compliance Officer and Conduct Committee Coordinator at Vale S/A. Since July 2023, he has also been a member of the Audit Committee of AEGEA Saneamento and member of the Excellence in Risks Committee at the Regional Administration Council (CRA). Between 2014 and 2017, he was the Corporate Governance Secretary at the Brazilian Institute of Corporate Governance (IBGC).
The Internal Regulation of the Audit Committee was duly approved by the Company’s Board of Directors on May 13, 2021 and is available: (i) at the Company’s headquarters: Avenida Juruá, 434, Alphaville, CEP 06455-010, Barueri/SP; and (ii) on the Company’s website (www.dasa.com.br).